Hamburg, Germany

Ksenia Egorova



Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2009-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ksenia Egorova: Innovator in Cyanide-Tolerant Nitrile Hydratases

Introduction

Ksenia Egorova is a prominent inventor based in Hamburg, Germany, who has made significant contributions to the field of biotechnology. With two patents to her name, she has demonstrated exceptional expertise in the development of cyanide-tolerant nitrile hydratases. Her work holds great potential for advancing methods in enzymatic preparation processes.

Latest Patents

Ksenia's latest patents include innovative technologies surrounding polynucleotides that code for cyanide-tolerant nitrile hydratases. One notable patent discloses cyanide-tolerant nitrile hydratases derived from specific strains that exhibit increased cyanide tolerance. This advancement shows promise in the efficient preparation of amides from nitriles in the presence of cyanides. Another patent focuses on the enzymatic processes for converting nitriles into amides, further emphasizing the significance of her research in the field.

Career Highlights

Currently, Ksenia is employed at Evonik Degussa GmbH, where she continues to push the boundaries of research and innovation. Her work at the company underscores a commitment to enhancing biotechnological applications and improving industrial processes through her findings.

Collaborations

Throughout her career, Ksenia has collaborated with notable colleagues such as Steffen Osswald and Christoph Weckbecker. These partnerships have fostered an environment of shared knowledge and innovation, contributing further to her research's impact in the biotechnology sector.

Conclusion

Ksenia Egorova stands out as a significant figure in the field of biotechnology. Her contributions, specifically in the area of cyanide-tolerant nitrile hydratases, mark her as an innovative inventor. As her career continues to evolve, she remains a valuable asset to the scientific community and a pioneer in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…